Pancreatic Cancer | Tumor

CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.

FDA Grants Compassionate Use Treatment to Namodenoson in Pancreatic Cancer

March 19th 2025, 3:00pm

Article

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient with pancreatic cancer.

FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer

March 17th 2025, 3:00pm

Article

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel treatment for the disease.

Tedopi Cancer Vaccine Meets Trial End Point For Pancreatic Cancer

March 12th 2025, 9:00pm

Article

The phase 2 TEDOPaM trial evaluating patients with advanced or metastatic pancreatic ductal adenocarcinoma met its primary end point.

Insights into the Latest Trends in Pancreatic Cancer

March 11th 2025, 8:57pm

Article

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.

My Cousin and I Journey Through Breast, Lung, Pancreatic and Prostate Cancer

February 27th 2025, 6:00pm

Article

After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I committed myself to being there for my cousin.

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

February 25th 2025, 4:00pm

Article

In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.

Facing Cancer Together: Jim and Melanie’s Patient-Caregiver Story

February 13th 2025, 6:00pm

Article

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's sarcoma diagnosis.

Pelareorep With Chemo and Tecentriq Shows Acceptable Safety in Metastatic PDAC

February 9th 2025, 7:00pm

Article

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma.

Pancreatic Cancer Diagnoses and Mortality Rates Rise

February 4th 2025, 9:32pm

Article

The recent American Cancer Society’s Cancer Statistics, 2025 report was released revealing a sobering trend for pancreatic cancer.

IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer

January 20th 2025, 10:00pm

Article

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.